Oxford-AstraZeneca's COVID-19 vaccine is at least 70 percent effective in late-stage trial


Oxford University and drugmaker AstraZeneca announced Monday morning that their COVID-19 vaccine candidate had proved to be 70 percent effective in its Phase Three trial of 20,000 volunteers in Britain and Brazil. And Oxford Vaccine Group director Andrew Pollard told BBC Radio 4 Today that the vaccine appeared to be 90 percent effective when people were given a half-dose of the vaccine followed by a full dose.
"We are really pleased with these results," Pollard said. "What we have got is a vaccine that is able to protect against coronavirus disease and, importantly, there were no hospitalizations or severe cases in anyone who had the Oxford vaccine." Sarah Gilbert, the vaccine's architect, said "the announcement today takes us another step closer to the time when we can use vaccines to bring an end to the devastation caused by" the new coronavirus.
Britain has ordered 100 million doses of the Oxford vaccine, and if U.K. regulators approve it for emergency use, the country is ready to roll out an aggressive immunization program. Residents and staff of nursing homes are first on the list of those approved for vaccinations, followed by health care workers and people over 85, then consecutively lower age groups.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"After Pfizer and Modena both produced vaccines delivering 95 percent protection from COVID-19, a figure of 70 percent is relatively disappointing," BBC News reports. "However, anything above 50 percent would have been considered a triumph just a month ago. This vaccine can also be stored at fridge temperature, which means it can be distributed to every corner of the world, unlike the Pfizer/BioNTech and Moderna vaccines, which need to be stored at much colder temperatures."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
How will the new tax deductions on auto loans work?
the explainer Trump's One Big Beautiful Bill Act introduced a tax deduction on auto loan interest — but eligibility for the tax break is limited
-
Is Trump actually going to prosecute Obama for 'treason'?
Today's Big Question Or is this just a distraction from the Jeffrey Epstein scandal?
-
5 best movie sequels of all time
The Week Recommends The second time is only sometimes as good as the first
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year
-
Economists fear US inflation data less reliable
speed read The Labor Department is collecting less data for its consumer price index due to staffing shortages
-
Crypto firm Coinbase hacked, faces SEC scrutiny
Speed Read The Securities and Exchange Commission has also been investigating whether Coinbase misstated its user numbers in past disclosures
-
Starbucks baristas strike over dress code
speed read The new uniform 'puts the burden on baristas' to buy new clothes, said a Starbucks Workers United union delegate
-
Warren Buffet announces surprise retirement
speed read At the annual meeting of Berkshire Hathaway, the billionaire investor named Vice Chairman Greg Abel his replacement
-
Trump calls Amazon's Bezos over tariff display
Speed Read The president was not happy with reports that Amazon would list the added cost from tariffs alongside product prices